User: Guest  Login
If you experience problems opening the document, please try this link.
Title:

Ramucirumab plus FOLFIRI or irinotecan as second-line treatment for patients with gastroesophageal adenocarcinoma: a review and meta-analysis of an emerging option

Document type:
Zeitschriftenaufsatz
Author(s):
Park, Haeseong ; Klempner, Samuel J. ; Chao, Joseph ; Wainberg, Zev A. ; Lukanowski, Mariusz ; Chenji, Suresh ; Bourke, Shannon ; Chatterjee, Anindya ; Lorenzen, Sylvie
Keywords:
Oncology ; ramucirumab ; gastroesophageal adenocarcinoma ; second-line ; irinotecan ; FOLFIRI
Journal title:
Frontiers in Oncology
Year:
2024
Journal volume:
14
Fulltext / DOI:
doi:10.3389/fonc.2024.1419338
Publisher:
Frontiers Media S.A.
E-ISSN:
2234-943X
Date of publication:
13.08.2024
CC license:
by, https://creativecommons.org/licenses/by/4.0
 BibTeX